A case of lupus‐like syndrome in a patient receiving adalimumab and a brief review of the literature on drug‐induced lupus erythematosus
Summary What is known and objective Drug‐induced lupus erythematosus occurs with some drugs and resolves with their withdrawal. Anti‐TNF therapies have been found to be associated with a lupus‐like syndrome, which is clinically distinct from classical drug‐induced as well as idiopathic lupus erythem...
Gespeichert in:
| Veröffentlicht in: | Journal of clinical pharmacy and therapeutics 2017-06, Vol.42 (3), p.363-366 |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 366 |
|---|---|
| container_issue | 3 |
| container_start_page | 363 |
| container_title | Journal of clinical pharmacy and therapeutics |
| container_volume | 42 |
| creator | Lomicová, I. Suchý, D. Pizinger, K. Cetkovská, P. |
| description | Summary
What is known and objective
Drug‐induced lupus erythematosus occurs with some drugs and resolves with their withdrawal. Anti‐TNF therapies have been found to be associated with a lupus‐like syndrome, which is clinically distinct from classical drug‐induced as well as idiopathic lupus erythematosus.
Case description
We describe a case of a patient with severe psoriasis, who developed muscle pain with paraesthesia accompanied by ANA titres elevation with adalimumab treatment. The condition resolved after adalimumab cessation, and the patient was started on ustekinumab with good results.
What is new and conclusion
Ustekinumab might be a useful treatment option for patients with a history of TNF‐induced lupus‐like syndrome.
Drug‐induced lupus erythematosus is a lupus‐like syndrome similar to idiopathic lupus erythematosus that occurs when certain drugs are taken and resolves after their withdrawal. Anti‐TNF α therapies have been found to be associated with a lupus‐like syndrome, which is clinically distinct from both classical drug‐induced lupus erythematosus and idiopathic form. We describe a case of a female patient with severe psoriasis, who developed muscle pain with paraesthesia accompanied by ANA titres elevation under adalimumab treatment. The condition resolved after adalimumab cessation. |
| doi_str_mv | 10.1111/jcpt.12506 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1897382774</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>4321960393</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4266-c30d05750c3d9ed6cb225e9156393fe34ee5c888ea44af68b03e33d304cd16193</originalsourceid><addsrcrecordid>eNqN0b1u1TAch2ELgeihsHAByBILQkrxt5OxOmr5UCUYyhw59j_Fh8QJdtzqbFxAB66RK8GnKQwMCC9eHr2W9UPoOSUntJw3OzsvJ5RJoh6gDeVKVkxT8hBtCFNNJTTTR-hJSjtCiNKMP0ZHrKYNVYpv0O0ptiYBnno85Dmnn99_DP4r4LQPLk4jYB-wwbNZPIQFR7Dgr324wsaZwY95NB02wRXSRQ99Adcebg615QvgwS8QzZJj6QfsYr4qeR9ctuDW5zDEfZGjWaaU01P0qDdDgmf39zH6fH52uX1XXXx8-357elFZwZSqLCeOSC2J5a4Bp2zHmISGSsUb3gMXANLWdQ1GCNOruiMcOHecCOuoog0_Rq_W7hynbxnS0o4-WRgGE2DKqaV1o3nNtBb_QZVuaiHvqi__orspx1A-cghSLmouZVGvV2XjlFKEvp2jH03ct5S0hznbw5zt3ZwFv7hP5m4E94f-3q8AuoIbP8D-H6n2w_bT5Rr9BVl6rT4</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1891348355</pqid></control><display><type>article</type><title>A case of lupus‐like syndrome in a patient receiving adalimumab and a brief review of the literature on drug‐induced lupus erythematosus</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Lomicová, I. ; Suchý, D. ; Pizinger, K. ; Cetkovská, P.</creator><creatorcontrib>Lomicová, I. ; Suchý, D. ; Pizinger, K. ; Cetkovská, P.</creatorcontrib><description>Summary
What is known and objective
Drug‐induced lupus erythematosus occurs with some drugs and resolves with their withdrawal. Anti‐TNF therapies have been found to be associated with a lupus‐like syndrome, which is clinically distinct from classical drug‐induced as well as idiopathic lupus erythematosus.
Case description
We describe a case of a patient with severe psoriasis, who developed muscle pain with paraesthesia accompanied by ANA titres elevation with adalimumab treatment. The condition resolved after adalimumab cessation, and the patient was started on ustekinumab with good results.
What is new and conclusion
Ustekinumab might be a useful treatment option for patients with a history of TNF‐induced lupus‐like syndrome.
Drug‐induced lupus erythematosus is a lupus‐like syndrome similar to idiopathic lupus erythematosus that occurs when certain drugs are taken and resolves after their withdrawal. Anti‐TNF α therapies have been found to be associated with a lupus‐like syndrome, which is clinically distinct from both classical drug‐induced lupus erythematosus and idiopathic form. We describe a case of a female patient with severe psoriasis, who developed muscle pain with paraesthesia accompanied by ANA titres elevation under adalimumab treatment. The condition resolved after adalimumab cessation.</description><identifier>ISSN: 0269-4727</identifier><identifier>EISSN: 1365-2710</identifier><identifier>DOI: 10.1111/jcpt.12506</identifier><identifier>PMID: 28191663</identifier><identifier>CODEN: JCPTED</identifier><language>eng</language><publisher>England: Hindawi Limited</publisher><subject>Adalimumab - administration & dosage ; Adalimumab - adverse effects ; Adult ; Anti-Inflammatory Agents - administration & dosage ; Anti-Inflammatory Agents - adverse effects ; anti‐TNF treatment ; drug‐induced lupus erythematosus ; Female ; Humans ; Lupus Erythematosus, Systemic - chemically induced ; lupus‐like syndrome ; Psoriasis - drug therapy ; Psoriasis - pathology ; Severity of Illness Index ; Tumor Necrosis Factor-alpha - antagonists & inhibitors ; ustekinumab ; Ustekinumab - therapeutic use</subject><ispartof>Journal of clinical pharmacy and therapeutics, 2017-06, Vol.42 (3), p.363-366</ispartof><rights>2017 John Wiley & Sons Ltd</rights><rights>2017 John Wiley & Sons Ltd.</rights><rights>Copyright © 2017 John Wiley & Sons Ltd</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4266-c30d05750c3d9ed6cb225e9156393fe34ee5c888ea44af68b03e33d304cd16193</citedby><cites>FETCH-LOGICAL-c4266-c30d05750c3d9ed6cb225e9156393fe34ee5c888ea44af68b03e33d304cd16193</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fjcpt.12506$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fjcpt.12506$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28191663$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Lomicová, I.</creatorcontrib><creatorcontrib>Suchý, D.</creatorcontrib><creatorcontrib>Pizinger, K.</creatorcontrib><creatorcontrib>Cetkovská, P.</creatorcontrib><title>A case of lupus‐like syndrome in a patient receiving adalimumab and a brief review of the literature on drug‐induced lupus erythematosus</title><title>Journal of clinical pharmacy and therapeutics</title><addtitle>J Clin Pharm Ther</addtitle><description>Summary
What is known and objective
Drug‐induced lupus erythematosus occurs with some drugs and resolves with their withdrawal. Anti‐TNF therapies have been found to be associated with a lupus‐like syndrome, which is clinically distinct from classical drug‐induced as well as idiopathic lupus erythematosus.
Case description
We describe a case of a patient with severe psoriasis, who developed muscle pain with paraesthesia accompanied by ANA titres elevation with adalimumab treatment. The condition resolved after adalimumab cessation, and the patient was started on ustekinumab with good results.
What is new and conclusion
Ustekinumab might be a useful treatment option for patients with a history of TNF‐induced lupus‐like syndrome.
Drug‐induced lupus erythematosus is a lupus‐like syndrome similar to idiopathic lupus erythematosus that occurs when certain drugs are taken and resolves after their withdrawal. Anti‐TNF α therapies have been found to be associated with a lupus‐like syndrome, which is clinically distinct from both classical drug‐induced lupus erythematosus and idiopathic form. We describe a case of a female patient with severe psoriasis, who developed muscle pain with paraesthesia accompanied by ANA titres elevation under adalimumab treatment. The condition resolved after adalimumab cessation.</description><subject>Adalimumab - administration & dosage</subject><subject>Adalimumab - adverse effects</subject><subject>Adult</subject><subject>Anti-Inflammatory Agents - administration & dosage</subject><subject>Anti-Inflammatory Agents - adverse effects</subject><subject>anti‐TNF treatment</subject><subject>drug‐induced lupus erythematosus</subject><subject>Female</subject><subject>Humans</subject><subject>Lupus Erythematosus, Systemic - chemically induced</subject><subject>lupus‐like syndrome</subject><subject>Psoriasis - drug therapy</subject><subject>Psoriasis - pathology</subject><subject>Severity of Illness Index</subject><subject>Tumor Necrosis Factor-alpha - antagonists & inhibitors</subject><subject>ustekinumab</subject><subject>Ustekinumab - therapeutic use</subject><issn>0269-4727</issn><issn>1365-2710</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqN0b1u1TAch2ELgeihsHAByBILQkrxt5OxOmr5UCUYyhw59j_Fh8QJdtzqbFxAB66RK8GnKQwMCC9eHr2W9UPoOSUntJw3OzsvJ5RJoh6gDeVKVkxT8hBtCFNNJTTTR-hJSjtCiNKMP0ZHrKYNVYpv0O0ptiYBnno85Dmnn99_DP4r4LQPLk4jYB-wwbNZPIQFR7Dgr324wsaZwY95NB02wRXSRQ99Adcebg615QvgwS8QzZJj6QfsYr4qeR9ctuDW5zDEfZGjWaaU01P0qDdDgmf39zH6fH52uX1XXXx8-357elFZwZSqLCeOSC2J5a4Bp2zHmISGSsUb3gMXANLWdQ1GCNOruiMcOHecCOuoog0_Rq_W7hynbxnS0o4-WRgGE2DKqaV1o3nNtBb_QZVuaiHvqi__orspx1A-cghSLmouZVGvV2XjlFKEvp2jH03ct5S0hznbw5zt3ZwFv7hP5m4E94f-3q8AuoIbP8D-H6n2w_bT5Rr9BVl6rT4</recordid><startdate>201706</startdate><enddate>201706</enddate><creator>Lomicová, I.</creator><creator>Suchý, D.</creator><creator>Pizinger, K.</creator><creator>Cetkovská, P.</creator><general>Hindawi Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TM</scope><scope>7TO</scope><scope>H94</scope><scope>K9.</scope><scope>M7N</scope><scope>7X8</scope></search><sort><creationdate>201706</creationdate><title>A case of lupus‐like syndrome in a patient receiving adalimumab and a brief review of the literature on drug‐induced lupus erythematosus</title><author>Lomicová, I. ; Suchý, D. ; Pizinger, K. ; Cetkovská, P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4266-c30d05750c3d9ed6cb225e9156393fe34ee5c888ea44af68b03e33d304cd16193</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adalimumab - administration & dosage</topic><topic>Adalimumab - adverse effects</topic><topic>Adult</topic><topic>Anti-Inflammatory Agents - administration & dosage</topic><topic>Anti-Inflammatory Agents - adverse effects</topic><topic>anti‐TNF treatment</topic><topic>drug‐induced lupus erythematosus</topic><topic>Female</topic><topic>Humans</topic><topic>Lupus Erythematosus, Systemic - chemically induced</topic><topic>lupus‐like syndrome</topic><topic>Psoriasis - drug therapy</topic><topic>Psoriasis - pathology</topic><topic>Severity of Illness Index</topic><topic>Tumor Necrosis Factor-alpha - antagonists & inhibitors</topic><topic>ustekinumab</topic><topic>Ustekinumab - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lomicová, I.</creatorcontrib><creatorcontrib>Suchý, D.</creatorcontrib><creatorcontrib>Pizinger, K.</creatorcontrib><creatorcontrib>Cetkovská, P.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of clinical pharmacy and therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lomicová, I.</au><au>Suchý, D.</au><au>Pizinger, K.</au><au>Cetkovská, P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A case of lupus‐like syndrome in a patient receiving adalimumab and a brief review of the literature on drug‐induced lupus erythematosus</atitle><jtitle>Journal of clinical pharmacy and therapeutics</jtitle><addtitle>J Clin Pharm Ther</addtitle><date>2017-06</date><risdate>2017</risdate><volume>42</volume><issue>3</issue><spage>363</spage><epage>366</epage><pages>363-366</pages><issn>0269-4727</issn><eissn>1365-2710</eissn><coden>JCPTED</coden><abstract>Summary
What is known and objective
Drug‐induced lupus erythematosus occurs with some drugs and resolves with their withdrawal. Anti‐TNF therapies have been found to be associated with a lupus‐like syndrome, which is clinically distinct from classical drug‐induced as well as idiopathic lupus erythematosus.
Case description
We describe a case of a patient with severe psoriasis, who developed muscle pain with paraesthesia accompanied by ANA titres elevation with adalimumab treatment. The condition resolved after adalimumab cessation, and the patient was started on ustekinumab with good results.
What is new and conclusion
Ustekinumab might be a useful treatment option for patients with a history of TNF‐induced lupus‐like syndrome.
Drug‐induced lupus erythematosus is a lupus‐like syndrome similar to idiopathic lupus erythematosus that occurs when certain drugs are taken and resolves after their withdrawal. Anti‐TNF α therapies have been found to be associated with a lupus‐like syndrome, which is clinically distinct from both classical drug‐induced lupus erythematosus and idiopathic form. We describe a case of a female patient with severe psoriasis, who developed muscle pain with paraesthesia accompanied by ANA titres elevation under adalimumab treatment. The condition resolved after adalimumab cessation.</abstract><cop>England</cop><pub>Hindawi Limited</pub><pmid>28191663</pmid><doi>10.1111/jcpt.12506</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0269-4727 |
| ispartof | Journal of clinical pharmacy and therapeutics, 2017-06, Vol.42 (3), p.363-366 |
| issn | 0269-4727 1365-2710 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1897382774 |
| source | MEDLINE; Access via Wiley Online Library |
| subjects | Adalimumab - administration & dosage Adalimumab - adverse effects Adult Anti-Inflammatory Agents - administration & dosage Anti-Inflammatory Agents - adverse effects anti‐TNF treatment drug‐induced lupus erythematosus Female Humans Lupus Erythematosus, Systemic - chemically induced lupus‐like syndrome Psoriasis - drug therapy Psoriasis - pathology Severity of Illness Index Tumor Necrosis Factor-alpha - antagonists & inhibitors ustekinumab Ustekinumab - therapeutic use |
| title | A case of lupus‐like syndrome in a patient receiving adalimumab and a brief review of the literature on drug‐induced lupus erythematosus |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T11%3A37%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20case%20of%20lupus%E2%80%90like%20syndrome%20in%20a%20patient%20receiving%20adalimumab%20and%20a%20brief%20review%20of%20the%20literature%20on%20drug%E2%80%90induced%20lupus%20erythematosus&rft.jtitle=Journal%20of%20clinical%20pharmacy%20and%20therapeutics&rft.au=Lomicov%C3%A1,%20I.&rft.date=2017-06&rft.volume=42&rft.issue=3&rft.spage=363&rft.epage=366&rft.pages=363-366&rft.issn=0269-4727&rft.eissn=1365-2710&rft.coden=JCPTED&rft_id=info:doi/10.1111/jcpt.12506&rft_dat=%3Cproquest_cross%3E4321960393%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1891348355&rft_id=info:pmid/28191663&rfr_iscdi=true |